Published in:
01-07-2010 | Case Report
Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib
Authors:
Marcel Seiz, Ingo Nölte, Ioannis Pechlivanis, Christian F. Freyschlag, Kirsten Schmieder, Peter Vajkoczy, Jochen Tuettenberg
Published in:
Neurosurgical Review
|
Issue 3/2010
Login to get access
Abstract
Glioblastoma multiforme is the most common and most malignant primary brain tumour. Prognosis after diagnosis remains poor despite recent advances in adjuvant therapy. Treatment of choice is gross surgical resection and combined radio-chemotherapy with temozolomide as chemotherapeutic agent. Experimental continuous low-dose chemotherapy with temozolomide in combination with a cyclooxygenase-2 inhibitor has shown encouraging effects on progression-free survival and overall survival in patients, but leads to a high proportion of distant recurrences. Here, we describe extreme far-distant metastases along the neural axis of glioblastoma multiforme in four patients receiving metronomic antiangiogenic chemotherapy and review the literature to discuss possible mechanisms.